In this article, we will discuss Golimumab (Monitoring to Assess Safety). So, let’s get started.
Golimumab (Monitoring to Assess Safety)
Prior to initiating Golimumab and periodically during therapy, patients should be evaluated for active tuberculosis and tested for latent infection.
Prior to initiating Golimumab, patients should be tested for hepatitis B viral infection.